China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed ...

Researchers at the Paul Scherrer Institute PSI, in collaboration with the National Institute of Standards and Technology ...

In a move to streamline regulatory oversight of medical devices, the Central Drugs Standard Control Organisation (CDSCO) has ...